Home Search
Abstracts
Browse
Oral Sessions
Browse
Poster Sessions
Program
Committee
Visit
WebSite
Contact
Us

 

Session 143  Poster Abstracts
ART-Associated Toxicities in Resource-Limited and Developed Countries
Tuesday, 1 - 4 pm
Poster Hall
      794 Low Level of Adverse Events in Patients on Integrated Standard DOT TB Therapy and Once Daily ddI+3TC+ EFV in a Rural Resource-constrained Setting in South Africa: Sizonq’oba 1-Year Outcomes
R Pawinski1, N Gandhi2, T Moll3, K Zeller4, U Lalloo5, Gerald Friedland*6, and Sizonq'oba
1Independant Consultant; 2Albert Einstein Coll of Med, Bronx, NY, US; 3Church of Scotland Hosp and Philanjalo, Tugela Ferry, South Africa; 4Brown Med Sch, Providence, RI, US; 5Nelson Mandela Sch of Med, Durban, South Africa; and 6Yale Univ Sch of Med, New Haven, CT, US
      795

High Rates of Non-fatal Toxicities in a 24-Month Cohort Receiving Publicly Funded HAART in South Africa
Emily B Wong*1, D Murdoch2, J Wing3, C Feldman3, and W Venter4
1Univ of California, San Francisco, US; 2Duke Univ Med Ctr, Durham, NC, US; 3Univ of the Witswatersrand, Johannesburg, South Africa; and 4Reproductive Hlth and HIV Res Unit, Johannesburg, South Africa
      796

Metabolic Complications of ART in Black South African Patients
Jaya George*, N Lutchman, and N Crowther
Natl Hlth Lab Svc, Univ of the Witwatersrand, Johannesburg, South Africa
      797

Experience Using AZT and d4T in TAHOD Patients: Treatment Duration and AZT-related Anemia
S Huffam1, P Srasuebkul2, J Zhou2, Alexandra Calmy*3, V Saphonn1, J Kaldor2, R Ditangco4, and The TREAT Asia HIV Observational Database (TAHOD)
1Natl Ctr for HIV/AIDS, Dermatology and STDs, Ministry of Hlth, Cambodia; 2Natl Ctr for HIV Epidemiology and Clin Res, Univ of New South Wales, Australia; 3St Vincent's Hosp, Sydney, Australia; and 4Res Inst for Tropical Med, Philippines
      798 NNRTI Use May Be Associated with Decreased Oxidant Stress during HIV Therapy
Leigh Anne Dageforde*1, A Shintani1, D Haas1, N Emeagwali2, M Markovic1, I Oboho1, C Mwenya1, E Acosta3, J Morrow1, and T Hulgan1
1Vanderbilt Univ Sch of Med, Nashville, TN, US; 2Meharry Med Coll, Nashville, TN, US; and 3Univ of Alabama at Birmingham Sch of Med, US
      799 Improved Toxicity Profile of Recent HAART Regimens
Luuk Gras*1, C Smit1, A van Sighem1, P Reiss2, F de Wolf1,3, and F de Wolf1,3
1HIV Monitoring Fndn, Amsterdam, The Netherlands; 2Ctr for Immunity and Infection, Academic Med Ctr, Univ of Amsterdam, The Netherlands; and 3Imperial Coll Sch of Med, London, UK